Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Establishing cardiovascular safety of new therapies for type 2 diabetes is important. Safety data are available for the subcutaneous form of the glucagon-like peptide-1 receptor...